Venture the Path Less Traveled^TM

“

I’ve worked with many venture capital investors over my career, but Tom Shehab and the team at Arboretum Ventures are more than investors; they're proactive, involved partners. They collaborate with us, leaning in to tackle challenges shoulder to shoulder. Their steady devotion and vast network have been catalysts for our growth in advancing neuromodulation for autoimmune diseases.

Heather SimonsenCEO – Boomerang Medical

“

Dan Kidle and the Arboretum team have exhibited profound dedication to nurturing our company's growth as we seek to revolutionize care for critically ill patients. Their involvement extends beyond just friendly advice; they are integral to our strategic decision-making process, offering invaluable insights, guidance, and connections.

Joe EiblCEO – Flosonics Medical

“

Jan is a leading advocate for innovations in healthcare across our world. Her focus and dedication to enable innovation in medical devices in particular, have had great impacts in human lives across various disease states. At Koya, as we focus on transforming venous and lymphatic care, having Jan not only invest through Arboretum but also provide her counsel, advocacy, and wisdom has greatly enabled our path forward. I am personally grateful for Jan’s support and strength that any founder or CEO would desire.

Andy Doraiswamy PhDCEO – Koya Medical

“

Beyond providing growth capital, Tim Petersen and Arboretum Ventures have quickly become an indispensable partner to Convergent Dental. Their contributions range from Tim’s thoughtful leadership on our board to making their impressive advisory board available to me to gain their insights on a variety of strategic topics. In fact, following a recent presentation to their advisory board, one of the members made himself available for a 1:1 mentoring discussion that materially influenced a recent transaction that are in the process of completing.

Rob GershonCEO – Convergent Dental

“

Paul McCreadie and the Arboretum team bring a solid foundation of investing experience and a deep network of industry partners that have helped shape our development strategy at Allay. I can rely on his consistent support and thoughtful approach to board discussions whether things are going well or if we are facing challenges.

Adam GridleyCEO – Allay Therapeutics